• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素和胰岛素样生长因子-I受体对胰岛素受体底物-1和胰岛素受体底物-2的差异性磷酸化作用。

Differential phosphorylation of IRS-1 and IRS-2 by insulin and IGF-I receptors.

作者信息

Rakatzi Irini, Stosik Magdalene, Gromke Tanja, Siddle Kenneth, Eckel Jürgen

机构信息

Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Düsseldorf, Germany.

出版信息

Arch Physiol Biochem. 2006 Feb;112(1):37-47. doi: 10.1080/13813450500500332.

DOI:10.1080/13813450500500332
PMID:16754202
Abstract

The specific contribution of insulin and IGF-I receptors to IRS-protein activation remains elusive. We studied the signalling properties of AspB10-insulin, an analog with enhanced affinity for the IGF-I receptor, in comparison to native insulin using primary human skeletal muscle cells. In myoblasts regular insulin and AspB10-insulin were equipotent in stimulating the IRS cascade, whereas this analog induced a significantly higher Shc phosphorylation. Phosphorylation of IRS-1 in response to insulin was inhibited equally by blocking either the insulin or the IGF-I receptor. IRS-1 activation by AspB10-insulin was only inhibited by blocking the IGF-I receptor. IRS-2 phosphorylation induced by both insulin and AspB10-insulin was nearly insensitive to blocking the insulin receptor, being predominantly mediated by the IGF-I receptor. We conclude that in myoblasts IRS-2, but not IRS-1, functions as preferred substrate for the IGF-I receptor. These data suggest a specific role for IRS-2 in growth and differentiation of human skeletal muscle.

摘要

胰岛素和胰岛素样生长因子-I(IGF-I)受体对胰岛素受体底物(IRS)蛋白激活的具体贡献仍不清楚。我们使用原代人骨骼肌细胞,研究了与天然胰岛素相比,对IGF-I受体具有更高亲和力的类似物AspB10-胰岛素的信号特性。在成肌细胞中,常规胰岛素和AspB10-胰岛素在刺激IRS级联反应方面效力相当,而这种类似物诱导的Shc磷酸化显著更高。通过阻断胰岛素或IGF-I受体,均可同等程度地抑制胰岛素诱导的IRS-1磷酸化。AspB10-胰岛素激活IRS-1仅被阻断IGF-I受体所抑制。胰岛素和AspB10-胰岛素诱导的IRS-2磷酸化对阻断胰岛素受体几乎不敏感,主要由IGF-I受体介导。我们得出结论,在成肌细胞中,IRS-2而非IRS-1是IGF-I受体的优先作用底物。这些数据表明IRS-2在人类骨骼肌生长和分化中具有特定作用。

相似文献

1
Differential phosphorylation of IRS-1 and IRS-2 by insulin and IGF-I receptors.胰岛素和胰岛素样生长因子-I受体对胰岛素受体底物-1和胰岛素受体底物-2的差异性磷酸化作用。
Arch Physiol Biochem. 2006 Feb;112(1):37-47. doi: 10.1080/13813450500500332.
2
A novel insulin analog with unique properties: LysB3,GluB29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1.一种具有独特性质的新型胰岛素类似物:赖氨酸B3、谷氨酸B29胰岛素可显著激活胰岛素受体底物2,但对胰岛素受体底物1的磷酸化作用微弱。
Diabetes. 2003 Sep;52(9):2227-38. doi: 10.2337/diabetes.52.9.2227.
3
Insulin receptor substrate-4 is expressed in muscle tissue without acting as a substrate for the insulin receptor.胰岛素受体底物-4在肌肉组织中表达,但不作为胰岛素受体的底物发挥作用。
Endocrinology. 2003 Apr;144(4):1211-8. doi: 10.1210/en.2002-220723.
4
Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts.细胞因子-激素相互作用:肿瘤坏死因子α损害成肌细胞中胰岛素样生长因子I受体的生物学活性和下游激活信号。
Endocrinology. 2003 Jul;144(7):2988-96. doi: 10.1210/en.2003-0087.
5
Myoblasts With Higher IRS-1 Levels Are Eliminated From the Normal Cell Layer During Differentiation.在分化过程中,IRS-1 水平较高的成肌细胞会从正常细胞层中被清除。
Front Endocrinol (Lausanne). 2020 Feb 28;11:96. doi: 10.3389/fendo.2020.00096. eCollection 2020.
6
Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells.中国仓鼠卵巢细胞中胰岛素和胰岛素样生长因子I受体对胰岛素受体底物-1的差异性磷酸化作用
J Endocrinol. 2001 Oct;171(1):153-62. doi: 10.1677/joe.0.1710153.
7
Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.胰岛素受体底物(IRS)蛋白IRS-1和IRS-2在胎儿棕色脂肪细胞胰岛素/胰岛素样生长因子-I途径中的差异信号传导。
Mol Endocrinol. 1998 May;12(5):688-97. doi: 10.1210/mend.12.5.0106.
8
Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.他莫昔芬可干扰乳腺癌细胞中的胰岛素样生长因子I受体(IGF-IR)信号通路。
Cancer Res. 1997 Jul 1;57(13):2606-10.
9
Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation.胰岛素样生长因子-I(IGF-I)依赖的pp42/44丝裂原活化蛋白激酶激活独立于IGF-I受体激酶激活和IRS-1酪氨酸磷酸化而发生。
Eur J Biochem. 1999 Dec;266(3):1147-57. doi: 10.1046/j.1432-1327.1999.00968.x.
10
Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.胰岛素受体底物-1和Shc在培养的人成纤维细胞早期传代中对胰岛素样生长因子I受体信号传导的作用
Endocrinology. 1997 Feb;138(2):741-50. doi: 10.1210/endo.138.2.4910.

引用本文的文献

1
The insulin receptor: a new target for cancer therapy.胰岛素受体:癌症治疗的新靶点。
Front Endocrinol (Lausanne). 2011 Dec 6;2:93. doi: 10.3389/fendo.2011.00093. eCollection 2011.
2
Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances.胰岛素和 IGF 受体信号特异性的分子基础:被忽视的角落和最新进展。
Front Endocrinol (Lausanne). 2012 Feb 28;3:34. doi: 10.3389/fendo.2012.00034. eCollection 2012.